AzTrials
AzTrials

HemodialysisNCT07156942

A Story-Based Game to Reduce Anxiety and Improve Compliance in Hemodialysis Patients: RCT

A study testing Story-Based Digital Game in people with Hemodialysis and Game-Based Learning, run by Afra ÇALIK at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This clinical study is testing whether a short, story-based digital game played during dialysis can help improve the health and well-being of patients receiving hemodialysis. The researchers believe that using a digital game with an engaging storyline may help reduce anxiety, increase knowledge about healthy eating… Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Hemodialysis, Game-Based Learning, Adherence
What is being tested?
Story-Based Digital Game
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Mar 2025to 30 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged between 18 and 80 years
  • Receiving regular hemodialysis treatment for at least 6 months
  • Oriented to time, place, and person
  • Minimum primary school education
  • Able and willing to provide informed consent

Who cannot join

  • Refusal to participate in the study
  • Inability to provide informed consent due to cognitive or communication difficulties

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Suleyman Demirel University

    Isparta

Other trials in Turkey (Türkiye)

About this study

Official title: Strategies to Strengthen Physical and Mental Health During Hemodialysis: Rhythm of Life

This clinical study is testing whether a short, story-based digital game played during dialysis can help improve the health and well-being of patients receiving hemodialysis. The researchers believe that using a digital game with an engaging storyline may help reduce anxiety, increase knowledge about healthy eating, and encourage patients to better follow their treatment plans.

The main hypothesis is that this interactive game will lead to lower anxiety levels, better understanding of dietary rules, and higher treatment adherence compared to standard care alone.

Being tested
Story-Based Digital Game
Keywords
digital game, hemodialysis, adherence, anxiety, serious games
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Story-Based Digital GameBehavioural

    Participants in this arm played a story-based digital game during their regular hemodialysis sessions. The game was administered once per week, with each session lasting approximately 10 to 15 minutes, over a 4-week period. The game was accessed via an online platform and designed to educate patients on dietary choices, fluid management, and dialysis self-care through interactive storytelling and decision-making tasks.

Study groups in NCT07156942
Study groupRoleWhat they receive
Story-Based Digital GameExperimentalParticipants in this arm received a short, story-based digital game intervention during their hemodialysis sessions. The game was played once per week for 4 weeks, with each session lasting approximately 10-15 minutes. The game aimed to reduce anxiety, improve treatment adherence, and increase dietary knowledge by engaging patients in interactive scenarios related to dialysis care.
Receives: Behavioral: Story-Based Digital Game
Standard CareNo interventionParticipants in this arm received standard hemodialysis care without any additional digital game or educational intervention. They followed the usual treatment routines provided by the dialysis unit.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Treatment Adherence Score

    Assessed using the End-Stage Renal Disease Adherence Questionnaire to measure adherence to dialysis schedules and treatment routines.

    Measured: Baseline, Week 2, Week 4

Secondary outcomes (2)
  1. Change in Dietary Knowledge Score

    Measured using the Hemodialysis Patients' Diet Knowledge Scale.

    Measured: Baseline, Week 2, Week 4

  2. Change in Anxiety Level

    Assessed using the State Anxiety Inventory (STAI-S) to measure perceived anxiety during treatment.

    Measured: Baseline, Week 2, Week 4

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2025
  2. Study start1 Mar 2025
  3. Primary completion1 Mar 2025
  4. Study completion30 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07156942
Sponsor's protocol ID
9566
Other IDs
Scientific Research Projects C
Status last verified
Aug 2025
First submitted
17 May 2025
Last updated
5 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared because the study results are currently under consideration for publication, and data sharing may interfere with the peer-review and publication process.

Questions about this trial

What is this clinical trial studying?

A study testing Story-Based Digital Game in people with Hemodialysis and Game-Based Learning, run by Afra ÇALIK at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Treatment Adherence Score (time frame: Baseline, Week 2, Week 4). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in